View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
April 26, 2011

Supreme Court to Rule on Pharma Firm Data Mining

The US Supreme Court will decide on whether to bar doctors from being pitched drugs depending on their prescription habits from name-brand pharmaceutical companies. The landmark case puts the US state of Vermont against companies that have sold prescription information to drug makers

By cms admin

The US Supreme Court will decide on whether to bar doctors from being pitched drugs depending on their prescription habits from name-brand pharmaceutical companies.

The landmark case puts the US state of Vermont against companies that have sold prescription information to drug makers, a practice known as ‘data-mining’, without prior consent of the doctors.

Although the state has a law to prohibit data-mining, companies that sell the information claim they put valuable drug information into the hands of physicians and a ruling against them would be against their freedom of speech.

Vermont had countered this argument by claiming that the practice violates patient-doctor confidentiality and that it is increasing the cost of prescription drugs, a stance supported by the Obama administration.

The Supreme Court began hearing cases on 26 April, with a decision expected by late June this year.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU